Search

Rocket Pharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

3.43 2.69

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.27

Max

3.34

Pagrindiniai rodikliai

By Trading Economics

Pajamos

171M

123M

Pelnas, tenkantis vienai akcijai

-0.15

Darbuotojai

202

EBITDA

182M

137M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+232.62% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-04

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

26M

424M

Ankstesnė atidarymo kaina

0.74

Ankstesnė uždarymo kaina

3.43

Naujienos nuotaikos

By Acuity

34%

66%

67 / 339 reitingas Healthcare

Rocket Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-11 22:36; UTC

Rocket Pharmaceuticals Inc is trading lower in after-market hours, continuing a trend of declines over the past four sessions and remaining below its 20-day moving average.

2026-09-08 20:07; UTC

Rocket Pharmaceuticals is declining today, pulling back from an early high amid notable session losses. The stock remains above its 20-day moving average.

2026-09-04 22:14; UTC

Rocket Pharmaceuticals Inc shares are lower in after-market hours following a weak session, despite trading above the 20-day moving average.

2026-09-03 20:07; UTC

Rocket Pharmaceuticals Inc shares are declining amid broader market pressure, with no specific news identified. Earlier, the stock pulled back from a session high.

2026-09-02 22:01; UTC

Rocket Pharmaceuticals shares lower in after-market trading, declining since Wednesday's close. This follows a weaker-than-expected job growth report from ADP.

2026-09-01 21:02; UTC

Rocket Pharmaceuticals Inc shares are lower in after-market hours, amid broader economic concerns and rising crude oil prices linked to geopolitical tensions.

2026-08-31 20:03; UTC

Rocket Pharmaceuticals is lower today amid broader market pressures and concerns over inflation and potential Federal Reserve tightening following comments from Warsh at Jackson Hole.

2026-08-28 23:26; UTC

Rocket Pharmaceuticals Inc shares are lower in after-market trading. Broader market expectations for a rate hike may be influencing investor sentiment.

2026-08-26 20:08; UTC

Rocket Pharmaceuticals is lower as biotechnology stocks face significant pressure, influencing its price action despite remaining above the 20-day moving average.

2026-08-25 23:16; UTC

Rocket Pharmaceuticals shares are lower in after-market hours, following unusual trading activity and a broader market decline influenced by falling crude oil prices.

2026-08-24 20:06; UTC

Rocket Pharmaceuticals shares are higher, reflecting broader market gains. The market peaked early, though no specific company news was identified for the price movement.

2026-08-21 19:51; UTC

Correlated Moves

Rocket Pharmaceuticals Inc is rising during Friday's session, supported by strength in the biotechnology sector. The stock remains above its 20-day moving average.

2026-08-20 20:06; UTC

Correlated Moves

Rocket Pharmaceuticals Inc is lower today, reflecting broader pressures in the biotechnology sector. The overall market is also trending downwards.

2026-08-19 20:02; UTC

Correlated Moves

Rocket Pharmaceuticals Inc shares are sharply higher today, reflecting strong momentum amid notable gains in biotechnology stocks and positive sector dynamics.

2026-08-18 19:46; UTC

Rocket Pharmaceuticals shares are lower today, reflecting a decline since Monday. Broader market trends and rising Treasury yields may be influencing investor sentiment.

2026-08-17 23:46; UTC

Rocket Pharmaceuticals Inc shares are higher in after-market trading, reflecting positive performance despite broader market pressures and no specific company news identified.

2026-08-14 22:01; UTC

Rocket Pharmaceuticals Inc is trading lower in after-market hours, with no specific news identified. Broader market concerns may be influencing the decline.

2026-08-13 19:56; UTC

Rocket Pharmaceuticals Inc shares are lower today, continuing a recent downward trend amid rising U.S. unemployment claims, with no specific company news identified.

2026-08-12 19:16; UTC

Rocket Pharmaceuticals Inc shares are lower today, with no specific news driving the decline. Earlier, the stock reached a session high before falling.

2026-08-11 20:02; UTC

News

Rocket Pharmaceuticals shares are lower after Wedbush cut its price target to $15, reflecting concerns over mixed second-quarter earnings results.

2026-08-10 23:26; UTC

News

Rocket Pharmaceuticals reported Q2 net income of $123.2 million, with EPS of $1.08, significantly exceeding estimates. Shares traded higher in after-market hours.

2026-08-08 00:01; UTC

Rocket Pharmaceuticals Inc. shares are higher in after-market trading, advancing modestly since Friday's close and remaining above its 20-day moving average.

2026-08-07 23:01; UTC

Rocket Pharmaceuticals Inc. shares have shown little change in after-market trading, remaining within a narrow band since Friday's close.

2026-08-06 23:06; UTC

Rocket Pharmaceuticals Inc is trading higher in after-market hours, remaining above its 20-day moving average amid no specific news to explain the movement.

2026-08-05 20:02; UTC

News

Rocket Pharmaceuticals is rising Wednesday, driven by a strong Biotechnology sub-sector. The stock remains above its 20-day moving average during the session.

2026-08-04 19:26; UTC

News
Event

Rocket Pharmaceuticals shares rise as Wedbush maintains Outperform rating with a $16 price target. The company also reported promising safety results in its Phase 2 trial.

2026-08-03 22:01; UTC

Event

Rocket Pharmaceuticals shares are lower in after-market trading despite a positive clinical safety update on its Phase 2 trial for RP-A501.

2026-07-31 22:01; UTC

Rocket Pharmaceuticals shares declined in after-hours trading, continuing a downward trend since Friday's close. The stock remains below its 20-day moving average.

2026-07-30 21:51; UTC

Rocket Pharmaceuticals is lower in after-market hours, reflecting declines in the Biotechnology sub-sector. The stock remains below its 20-day moving average.

2026-07-29 20:52; UTC

Rocket Pharmaceuticals shares are lower in after-market hours amid a broader market decline driven by rising crude oil prices and geopolitical tensions.

Akcijų palyginimas

Kainos pokytis

Rocket Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

232.62% į viršų

12 mėnesių prognozė

Vidutinis 11.143 USD  232.62%

Aukščiausias 15 USD

Žemiausias 5 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Rocket Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

9 ratings

6

Pirkti

3

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

67 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure; Plakophilin-2 Arrhythmogenic Cardiomyopathy, an inheritable cardiac disorder; and BAG3 Dilated Cardiomyopathy. It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey.
help-icon Live chat